Wells and Geneva decision rules to predict pulmonary embolism: can we use them in Covid-19 patients?

Pulmonary embolism (PE) is a recognized complication of SARS-COV2 infection due to hypercoagulability. Before the COVID era, the need for computed tomography pulmonary angiography (CTPA) to rule out PE was determined by clinical probability, based on Wells and Geneva scores, in association with D-dimer measurements. However, patients with SARS-COV2 infection have a pro-thrombotic and pro-inflammatory state which may compromise the usefulness of these algorithms to select patients for CTPA.

Descrição

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2021. For permissions please email: Journals.permissions@oup.com. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

URI

http://hdl.handle.net/10451/50822

Citação

European Heart Journal - Cardiovascular Imaging, Vol. 22, Issue Supp. 3, June 2021, jeab111.009

Editora

Oxford University Press

DOI

10.1093/ehjci/jeab111.009

Coleções

FM-CCUL-Artigos em Revistas Internacionais

Métricas Alternativas

Ver registo completo